Volume: 8 Issue: 2
Year: 2020, Page: 7-9, Doi: https://doi.org/10.47799/pimr.0802.04
Introduction: Deletion of critical regions on long arm of chromosome 7 is important in pathogenesis of acute myeloid leukemia (AML). These regions include 7q22 and 7q31 which carry certain tumor suppressor genes which if deleted can result in uncontrolled division of myeloid cells. Aims: To estimate prevalence of 7q deletion in patients with acute myeloid leukemia (AML).
Materials and methods: Retrospective study was done on 25 bone marrow samples diagnosed with Acute myeloid leukemia referred to Division of Human Genetics St.John’s Medical college, Bangalore. Samples were subjected to standard protocol for karyotyping and FISH. Percentage of patients who were positive for 7q deletion was calculated.
Results: Out of 25 samples, 5 samples were positive for 7 q deletion accounting to 20% of total patients diagnosed with AML.
Conclusion: Presence of 7q deletion can be a poor prognostic marker since tumour suppressor genes are present in these regions. Hence cytogenetic markers are very important in deciding treatment and prognosis in these patients.
Keywords: 7q deletion, Acute Myeloid leukemia ,FISH, Karyotyping
1) Shi LH, Ma P, Liu JS, et al. Current views of chromosomal abnormalities in pediatric acute myeloid leukemia (AML). Eur Rev Med Pharmacol Sci. 2017;21:25-30.
2) Marchesi F, Annibali O, Cerchiara E, Tirindelli Mc, Avvisati G. Cytogenetic Abnormalities In Adult Non-Promyelocytic Acute myeloid leukemia: a concise review. Crit Rev Oncol Hematol 2011; 80: 331-346.
3) Heba N. Abdelrazik, Hala M. Farawila, Mai A Sherif, Mervat AlAnsary. Molecular characterization of chromosome 7 in AML and MDS patients. Afr J Health Sci. 2006;13:33- 42.
4) El-Menoufy MAM, Mourad ZI, Farahat NM. The prognostic impact of loss of chromosome 7 material detected by fluorescence in situ hybridization (FISH) in myeloid malignancies. J Egypt Natl Canc Inst. 2018;30:133-138.
5) Wang ML, Bailey NG. Acute Myeloid Leukemia Genetics: Risk Stratification and Implications for Therapy. Arch Pathol Lab Med. 2015;139:1215-1223.
6) Liang H, Fairman J, Claxton DF, Nowell PC, Green ED, Nagarajan L. Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical loci. Proc Natl Acad Sci U S A. 1998;95:3781-3785.
7) Poiré X, Labopin M, Polge E, et al. The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLAmatched allogeneic stem cell transplantation. Am J Hematol. 2020;95:282-294.
8) Hasle H, Alonzo TA, Auvrignon A, et al. Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study. Blood. 2007;109:4641-4647.
Shastry A, Subramaniam A, Tilak P. Prevalence of 7q deletion in patients with acute myeloid leukemia. Perspectives in Medical Research 2020; 8 (2):7-9 DOI : 10.47799/pimr.0802.04